Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies

Satu Männistö, Stephanie A. Smith-Warner, Donna Spiegelman, Demetrius Albanes, Kristin Anderson, Piet A. Van Den Brandt, James R. Cerhan, Graham Colditz, Diane Feskanich, Jo L. Freudenheim, Edward Giovannucci, R. Alexandra Goldbohm, Saxon Graham, Anthony B. Miller, Thomas E. Rohan, Jarmo Virtamo, Walter C. Willett, David J. Hunter

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Intervention trials with supplemental β-carotene have observed either no effect or a harmful effect on lung cancer risk. Because food composition databases for specific carotenoids have only become available recently, epidemiological evidence relating usual dietary levels of these carotenoids with lung cancer risk is limited. We analyzed the association between lung cancer risk and intakes of specific carotenoids using the primary data from seven cohort studies in North America and Europe. Carotenoid intakes were estimated from dietary questionnaires administered at baseline in each study. We calculated study-specific multivariate relative risks (RRs) and combined these using a random-effects model. The multivariate models included smoking history and other potential risk factors. During follow-up of up to 7-16 years across studies, 3,155 incident lung cancer cases were diagnosed among 399,765 participants. β-Carotene intake was not associated with lung cancer risk (pooled multivariate RR = 0.98; 95% confidence interval, 0.87-1.11; highest versus lowest quintile). The RRs for α-carotene, lutein/zeaxanthin, and lycopene were also close to unity. β-Cryptoxanthin intake was inversely associated with lung cancer risk (RR = 0.76; 95% confidence interval, 0.67-0. 86; highest versus lowest quintile). These results did not change after adjustment for intakes of vitamin C (with or without supplements), folate (with or without supplements), and other carotenoids and multivitamin use. The associations generally were similar among never, past, or current smokers and by histological type. Although smoking is the strongest risk factor for lung cancer, greater intake of foods high in β-cryptoxanthin, such as citrus fruit, may modestly lower the risk.

Original languageEnglish (US)
Pages (from-to)40-48
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume13
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Carotenoids
Lung Neoplasms
Cohort Studies
Smoking
Confidence Intervals
Lutein
Citrus
North America
Folic Acid
Ascorbic Acid
Eating
History
Databases
Food

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Männistö, S., Smith-Warner, S. A., Spiegelman, D., Albanes, D., Anderson, K., Van Den Brandt, P. A., ... Hunter, D. J. (2004). Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies. Cancer Epidemiology Biomarkers and Prevention, 13(1), 40-48. https://doi.org/10.1158/1055-9965.EPI-038-3

Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies. / Männistö, Satu; Smith-Warner, Stephanie A.; Spiegelman, Donna; Albanes, Demetrius; Anderson, Kristin; Van Den Brandt, Piet A.; Cerhan, James R.; Colditz, Graham; Feskanich, Diane; Freudenheim, Jo L.; Giovannucci, Edward; Goldbohm, R. Alexandra; Graham, Saxon; Miller, Anthony B.; Rohan, Thomas E.; Virtamo, Jarmo; Willett, Walter C.; Hunter, David J.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 13, No. 1, 01.2004, p. 40-48.

Research output: Contribution to journalArticle

Männistö, S, Smith-Warner, SA, Spiegelman, D, Albanes, D, Anderson, K, Van Den Brandt, PA, Cerhan, JR, Colditz, G, Feskanich, D, Freudenheim, JL, Giovannucci, E, Goldbohm, RA, Graham, S, Miller, AB, Rohan, TE, Virtamo, J, Willett, WC & Hunter, DJ 2004, 'Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies', Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 1, pp. 40-48. https://doi.org/10.1158/1055-9965.EPI-038-3
Männistö S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, Van Den Brandt PA et al. Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies. Cancer Epidemiology Biomarkers and Prevention. 2004 Jan;13(1):40-48. https://doi.org/10.1158/1055-9965.EPI-038-3
Männistö, Satu ; Smith-Warner, Stephanie A. ; Spiegelman, Donna ; Albanes, Demetrius ; Anderson, Kristin ; Van Den Brandt, Piet A. ; Cerhan, James R. ; Colditz, Graham ; Feskanich, Diane ; Freudenheim, Jo L. ; Giovannucci, Edward ; Goldbohm, R. Alexandra ; Graham, Saxon ; Miller, Anthony B. ; Rohan, Thomas E. ; Virtamo, Jarmo ; Willett, Walter C. ; Hunter, David J. / Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies. In: Cancer Epidemiology Biomarkers and Prevention. 2004 ; Vol. 13, No. 1. pp. 40-48.
@article{6b828812b5b746f987bdb8bdd029f047,
title = "Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies",
abstract = "Intervention trials with supplemental β-carotene have observed either no effect or a harmful effect on lung cancer risk. Because food composition databases for specific carotenoids have only become available recently, epidemiological evidence relating usual dietary levels of these carotenoids with lung cancer risk is limited. We analyzed the association between lung cancer risk and intakes of specific carotenoids using the primary data from seven cohort studies in North America and Europe. Carotenoid intakes were estimated from dietary questionnaires administered at baseline in each study. We calculated study-specific multivariate relative risks (RRs) and combined these using a random-effects model. The multivariate models included smoking history and other potential risk factors. During follow-up of up to 7-16 years across studies, 3,155 incident lung cancer cases were diagnosed among 399,765 participants. β-Carotene intake was not associated with lung cancer risk (pooled multivariate RR = 0.98; 95{\%} confidence interval, 0.87-1.11; highest versus lowest quintile). The RRs for α-carotene, lutein/zeaxanthin, and lycopene were also close to unity. β-Cryptoxanthin intake was inversely associated with lung cancer risk (RR = 0.76; 95{\%} confidence interval, 0.67-0. 86; highest versus lowest quintile). These results did not change after adjustment for intakes of vitamin C (with or without supplements), folate (with or without supplements), and other carotenoids and multivitamin use. The associations generally were similar among never, past, or current smokers and by histological type. Although smoking is the strongest risk factor for lung cancer, greater intake of foods high in β-cryptoxanthin, such as citrus fruit, may modestly lower the risk.",
author = "Satu M{\"a}nnist{\"o} and Smith-Warner, {Stephanie A.} and Donna Spiegelman and Demetrius Albanes and Kristin Anderson and {Van Den Brandt}, {Piet A.} and Cerhan, {James R.} and Graham Colditz and Diane Feskanich and Freudenheim, {Jo L.} and Edward Giovannucci and Goldbohm, {R. Alexandra} and Saxon Graham and Miller, {Anthony B.} and Rohan, {Thomas E.} and Jarmo Virtamo and Willett, {Walter C.} and Hunter, {David J.}",
year = "2004",
month = "1",
doi = "10.1158/1055-9965.EPI-038-3",
language = "English (US)",
volume = "13",
pages = "40--48",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies

AU - Männistö, Satu

AU - Smith-Warner, Stephanie A.

AU - Spiegelman, Donna

AU - Albanes, Demetrius

AU - Anderson, Kristin

AU - Van Den Brandt, Piet A.

AU - Cerhan, James R.

AU - Colditz, Graham

AU - Feskanich, Diane

AU - Freudenheim, Jo L.

AU - Giovannucci, Edward

AU - Goldbohm, R. Alexandra

AU - Graham, Saxon

AU - Miller, Anthony B.

AU - Rohan, Thomas E.

AU - Virtamo, Jarmo

AU - Willett, Walter C.

AU - Hunter, David J.

PY - 2004/1

Y1 - 2004/1

N2 - Intervention trials with supplemental β-carotene have observed either no effect or a harmful effect on lung cancer risk. Because food composition databases for specific carotenoids have only become available recently, epidemiological evidence relating usual dietary levels of these carotenoids with lung cancer risk is limited. We analyzed the association between lung cancer risk and intakes of specific carotenoids using the primary data from seven cohort studies in North America and Europe. Carotenoid intakes were estimated from dietary questionnaires administered at baseline in each study. We calculated study-specific multivariate relative risks (RRs) and combined these using a random-effects model. The multivariate models included smoking history and other potential risk factors. During follow-up of up to 7-16 years across studies, 3,155 incident lung cancer cases were diagnosed among 399,765 participants. β-Carotene intake was not associated with lung cancer risk (pooled multivariate RR = 0.98; 95% confidence interval, 0.87-1.11; highest versus lowest quintile). The RRs for α-carotene, lutein/zeaxanthin, and lycopene were also close to unity. β-Cryptoxanthin intake was inversely associated with lung cancer risk (RR = 0.76; 95% confidence interval, 0.67-0. 86; highest versus lowest quintile). These results did not change after adjustment for intakes of vitamin C (with or without supplements), folate (with or without supplements), and other carotenoids and multivitamin use. The associations generally were similar among never, past, or current smokers and by histological type. Although smoking is the strongest risk factor for lung cancer, greater intake of foods high in β-cryptoxanthin, such as citrus fruit, may modestly lower the risk.

AB - Intervention trials with supplemental β-carotene have observed either no effect or a harmful effect on lung cancer risk. Because food composition databases for specific carotenoids have only become available recently, epidemiological evidence relating usual dietary levels of these carotenoids with lung cancer risk is limited. We analyzed the association between lung cancer risk and intakes of specific carotenoids using the primary data from seven cohort studies in North America and Europe. Carotenoid intakes were estimated from dietary questionnaires administered at baseline in each study. We calculated study-specific multivariate relative risks (RRs) and combined these using a random-effects model. The multivariate models included smoking history and other potential risk factors. During follow-up of up to 7-16 years across studies, 3,155 incident lung cancer cases were diagnosed among 399,765 participants. β-Carotene intake was not associated with lung cancer risk (pooled multivariate RR = 0.98; 95% confidence interval, 0.87-1.11; highest versus lowest quintile). The RRs for α-carotene, lutein/zeaxanthin, and lycopene were also close to unity. β-Cryptoxanthin intake was inversely associated with lung cancer risk (RR = 0.76; 95% confidence interval, 0.67-0. 86; highest versus lowest quintile). These results did not change after adjustment for intakes of vitamin C (with or without supplements), folate (with or without supplements), and other carotenoids and multivitamin use. The associations generally were similar among never, past, or current smokers and by histological type. Although smoking is the strongest risk factor for lung cancer, greater intake of foods high in β-cryptoxanthin, such as citrus fruit, may modestly lower the risk.

UR - http://www.scopus.com/inward/record.url?scp=9144260520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144260520&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-038-3

DO - 10.1158/1055-9965.EPI-038-3

M3 - Article

VL - 13

SP - 40

EP - 48

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -